ADVERTISEMENT

SMS Lifesciences Hits 26 Straight Upper Circuits After Listing

This Stock Hit Upper Circuit Every Day Since Listing On August 17.



An employee arranges medicine bottles during the manufacture of pharmaceuticals inside Teva Pharmaceutical’s new factory in Godollo, Hungary. (Photographer: Akos Stiller/Bloomberg)
An employee arranges medicine bottles during the manufacture of pharmaceuticals inside Teva Pharmaceutical’s new factory in Godollo, Hungary. (Photographer: Akos Stiller/Bloomberg)

Shares of SMS Lifesciences India Ltd. hit upper circuit, the maximum possible gain in a day, in each of the 26 trading sessions since it debuted on stock markets on August 17.

The stock nearly quadrupled during the period, making it the best performer over the last one month among Indian companies. The active pharmaceutical ingredients and intermediaries maker’s market capitalisation has grown from Rs 41 crore to Rs 158 crore during the period.

Parent SMS Pharma carved out the lifesciences business into a separate entity in order to reduce the impact of semi-regulated units on regulated units, achieving operational efficiencies and streamlining its current structure.

Promoters hold 68 percent in SMS Lifesciences.